Online Inquiry
Cat.#: ACPP-1220
| Despition | ELOVL4 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1111 | Recombinant Human NRG1 Protein (Fc Tag) (AC1111) | 50 µg | inquiry |
| ACPP-1643 | Human Transthyretin Protein (AC1643) | 5 µg | inquiry |
| ACPP-1231 | Prominin 1 Blocking Peptide (AC1231) | 250 µg | inquiry |
| ACPP-1238 | LIMK1 Blocking Peptide (AC1238) | 250 µg | inquiry |
| ACPP-1513 | Human FGFR2 Protein (AC1513) | 2 µg | inquiry |
| ACPP-1670 | Mouse BDNF Protein (AC1670) | 2 µg | inquiry |
| ACPP-1279 | NEDD4 Blocking Peptide (AC1279) | 250 µg | inquiry |
| ACPP-1680 | Human DOK4 Protein (AC1680) | 5 µg | inquiry |
| ACPP-1041 | Recombinant Human Wnt3a Protein (AC1041) | 50 µg | inquiry |
| ACPP-1613 | Human RAB3IL1 Protein (AC1613) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.